This White Paper explores the potential impact of artificial intelligence on clinical trials. It delves into AI innovations, including Generative and agentic AI tools, that are working to improve efficiency and quality in clinical research. The paper reviews how AI-driven solutions such as scientific chatbots, data review tools, and a monitoring platform are enhancing protocol adherence, data accuracy, and oversight in clinical trials. It is authored by IQVIA experts Jonas Renström and Laurence Lin.